<?xml version="1.0" encoding="UTF-8" ?>

    <journal>
    <language>en</language>
    <journal_id_issn>2008-2835</journal_id_issn>
    <journal_id_issn_online>2008-4625</journal_id_issn_online>
    <journal_id_pii></journal_id_pii>
    <journal_id_doi></journal_id_doi>
    <journal_id_isnet></journal_id_isnet>
    <journal_id_iranmedex>276</journal_id_iranmedex>
    <journal_id_magiran>5669</journal_id_magiran>
    <journal_id_sid>11181</journal_id_sid>
    <pubdate>
	    <type>gregorian</type>
	    <year>>2019</year>
	    <month>>January-March</month>
	    <day></day>
    </pubdate>
    <volume>11</volume>
    <number>1</number>
    <publish_type>online</publish_type>
    <publish_edition>1</publish_edition>
    <article_type>fulltext</article_type>
    <articleset>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>30800245</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>The Effect of TAX-1 Gene of Human T-cell Leukemia Virus Type -1 on the Expression of CCR5 in K562 Cell Line</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;Background: Tax-1 protein of Human T-cell Leukemia Virus type 1(HTLV-1) serves as a key transcriptional regulatory gene product and has a crucial role in transactivating genes of infected cells by employing their transcriptional factors. This modulation includes induction of genes which encode CC-chemokines and their receptors. In this study, a recombinant vector containing Tax-1 gene was made and tested for its ability to induce CCR5 (CC chemokine receptor 5) expression in K562 cell line.&lt;br /&gt;
Methods: In order to perform this research, two blood samples of HTLV-1 positive were obtained from Urmia blood transfusion center. After DNA extraction, a complete sequence of &lt;em&gt;Tax-1&lt;/em&gt; gene was amplified by specific primers. Recombinant vectors carrying Tax-1 gene were synthesized and transformed into &lt;em&gt;Escherichia coli (E. coli)&lt;/em&gt;. After bacteria transformation, bacteria containing recombinant plasmid were selected and purified. Then, the recombinant shuttle vectors, &lt;em&gt;pCDNA3.1-TAX&lt;/em&gt;, were transfected into the cell culture (K562 cell line). Expression of &lt;em&gt;CCR5&lt;/em&gt; was measured after 72 &lt;em&gt;hr&lt;/em&gt; by Syber Green Real-Time PCR method compared to control cell culture. Normalization was done with GAPDH as a standard gene.&lt;br /&gt;
Results: Cloning of &lt;em&gt;Tax-1&lt;/em&gt; gene in the vector, &lt;em&gt;pCDNA3&lt;/em&gt;.1 was confirmed by colony PCR, restriction digestion, and sequencing methods. Expression of &lt;em&gt;Tax-1&lt;/em&gt; and &lt;em&gt;CCR5&lt;/em&gt; genes were confirmed by real time PCR and also, expression of &lt;em&gt;CCR5&lt;/em&gt; gene showed an 8-fold increase in comparison to mock-treated controls (p&amp;lt;0.05).&lt;br /&gt;
Conclusion: Our data suggested that recombinant &lt;em&gt;Tax-1&lt;/em&gt; may have the enhancing effect on CCR5 expression rate at mRNA levels in K562 cell line. Further studies are necessary to evaluate the effect of&lt;em&gt; pCDNA3.1-TAX&lt;/em&gt; on cell surface CCR5 expression.&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>CCR5, Human T-cell Leukemia Virus, Tax-1 protein</keyword>
	<start_page>67</start_page>
	<end_page>71</end_page>
	<web_url>https://www.ajmb.org/En/Article.aspx?id=10354</web_url>
    <pdf_url>https://www.ajmb.org/PDF/En/FullText/10354.pdf</pdf_url>
	<author_list><author><first_name>Nasrin</first_name><middle_name></middle_name><last_name>Haghnazari Sadaghiani</last_name><suffix></suffix><affiliation>Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>11394</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Lila</first_name><middle_name></middle_name><last_name>Pirayeshfard</last_name><suffix></suffix><affiliation>Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>11486</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Afsaneh</first_name><middle_name></middle_name><last_name>Aghaie</last_name><suffix></suffix><affiliation>Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>11475</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Zohreh</first_name><middle_name></middle_name><last_name>Sharifi</last_name><suffix></suffix><affiliation>Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>640</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

</articleset>
</journal>

